chapter  5
The emergence of commercial biotechnology in Japan
Pages 28

Compared with the US, Japan’s biotechnology sector has achieved modest commercial success. According to figures on the size of national biotechnology markets compiled by Japan’s Patent Office, the market for biotechnology products in Japan reached 834 billion yen in 1999, only about one-sixth the size of the 5.2 trillion yen market in the US, and less than half the size of the 2.4 trillion yen market in the European Union.1

Product sales are growing rapidly, however, topping 1.3 trillion yen in 2001, a seven-fold increase over the past twelve years; they are expected to approach 25 trillion yen by 2010.